Key result
Wearables improve hypertension outcomes best when embedded in comprehensive care pathways rather than stand-alone therapies.
Why the study?
Hypertension remains poorly controlled worldwide despite effective treatment, leading to an evaluation of whether wearable devices support self-management, which components are clinically useful, and why long-term adoption often fails.
Do wearable and connected devices improve hypertension self-management and clinical outcomes in adults with hypertension?
Do wearable and connected devices improve hypertension self-management and clinical outcomes in adults with hypertension?
Wearable devices for hypertension are most effective when integrated into a structured care pathway with clinical feedback and medication titration, rather than used as standalone tracking tools.
May support embedding wearables in supported hypertension pathways; leaves open prospective validation of cuffless devices.
Background: Hypertension remains poorly controlled worldwide despite the availability of effective treatment. Wearable devices may support self-management by combining blood pressure monitoring, physical activity feedback, reminders, and digital communication outside clinic visits. Objective: This review evaluates whether wearable and connected devices improve hypertension self-management, which components appear clinically useful, and why long-term adoption often fails. Materials and Methods: A structured narrative review was conducted using English-language publications available through June 2026. Thirty sources were included, comprising randomized trials, systematic reviews, professional statements, validation studies, and qualitative research. Results: Wearable or connected monitoring appears most useful when it is embedded in a care pathway that includes reliable measurement, feedback, education, medication titration, or professional support. Activity tracking or self-measurement alone produces small, inconsistent, or absent blood pressure effects. Cuffless blood pressure devices may reduce measurement burden and capture patterns across daily life, but calibration drift, position effects, proprietary algorithms, and incomplete validation currently limit their use for diagnosis or treatment decisions. Sustained engagement depends on usability, perceived value, trust, tailored feedback, social support, and integration with clinical workflows. Conclusions: Wearables should be treated as components of an organized self-management system rather than stand-alone therapies. Future implementation should prioritize validated measurement, low-burden design, human support, interoperability, and equity-sensitive evaluation over device novelty.
No takes yet. Share an insight, caveat, or question.
Sciepuro et al. (2026) conducted a review in Hypertension. Wearable and connected devices vs. Usual care or unguided self-monitoring was evaluated on Blood pressure reduction and self-management engagement. Wearable devices improve hypertension outcomes most effectively when embedded in a comprehensive care pathway that includes reliable measurement, feedback, and medication titration, rather than as stand-alone therapies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: